Quick Heal Technologies Limited
Quick Heal Technologies Limited Fundamental Analysis
Quick Heal Technologies Limited (QUICKHEAL.BO) shows weak financial fundamentals with a PE ratio of 157.91, profit margin of 2.08%, and ROE of 1.30%. The company generates $2.8B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 41.1/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze QUICKHEAL.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakQUICKHEAL.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateQUICKHEAL.BO shows balanced valuation metrics.
Growth Score
ModerateQUICKHEAL.BO shows steady but slowing expansion.
Financial Health Score
ExcellentQUICKHEAL.BO maintains a strong and stable balance sheet.
Profitability Score
WeakQUICKHEAL.BO struggles to sustain strong margins.
Key Financial Metrics
Is QUICKHEAL.BO Expensive or Cheap?
P/E Ratio
QUICKHEAL.BO trades at 157.91 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, QUICKHEAL.BO's PEG of 0.16 indicates potential undervaluation.
Price to Book
The market values Quick Heal Technologies Limited at 2.04 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 56.75 times EBITDA. This signals the market has high growth expectations.
How Well Does QUICKHEAL.BO Make Money?
Net Profit Margin
For every $100 in sales, Quick Heal Technologies Limited keeps $2.08 as profit after all expenses.
Operating Margin
Core operations generate -7.93 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.30 in profit for every $100 of shareholder equity.
ROA
Quick Heal Technologies Limited generates $1.06 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Quick Heal Technologies Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Quick Heal Technologies Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
QUICKHEAL.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
157.91
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.16
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.04
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.28
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.23
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.01
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
-0.05
vs 25 benchmark
How QUICKHEAL.BO Stacks Against Its Sector Peers
| Metric | QUICKHEAL.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 157.91 | 35.62 | Worse (Expensive) |
| ROE | 1.30% | 1160.00% | Weak |
| Net Margin | 2.08% | -136515.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 4.23 | 4.79 | Strong Liquidity |
| ROA | 1.06% | -311498.00% (disorted) | Weak |
QUICKHEAL.BO outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Quick Heal Technologies Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta